ZENTIVA
ISIN: NL0000405173
Delisted issue
Information about issue
| Kind of investment instrument | share |
|---|
| Security kind | in the name of |
|---|
| Security form | certificated |
|---|
| Nominal value [EUR] | 0.010 |
|---|
| Market | Main market |
|---|
| Trading group | 3 |
|---|
| Number of issued pieces | 39,122,750 |
|---|
| Trading currency | CZK |
|---|
| Gross yield per unit for 12/31/2007 [CZK] | 7.40 |
|---|
Issuer's business activity
Zentiva N.V. is an international pharmaceutical company focused on selling, manufacturing and developing modern branded generic pharmaceutical products. Zentiva's key markets are the Czech Republic, Turkey, Romania, Slovakia, Poland and Russia. In addition to its core markets Zentiva is developing its business in a number of other countries in Central and Eastern Europe. The company addresses a wide range of therapeutic areas with a particular focus on areas that are treated mainly by primary care physicians - cardiovascular disorders, inflammatory conditions, pain, infection, diseases of the central nervous system and the gastrointestinal and urology fields. Zentiva's main product categories are branded prescription pharmaceutical products, branded consumer health care pharmaceutical products and active pharmaceutical ingredients (APIs). The majority of APIs are produced for internal company purposes. Zentiva has production sites in the Czech Republic, Slovakia, Romania, and Turkey.
Price [CZK]
Trade value
[CZKthnd]